Cabaletta Bio to Present at the H.C. Wainwright Global Investment Conference
PHILADELPHIA, May 17, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
PHILADELPHIA, May 17, 2022 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology…
REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Jasper Therapeutics, Inc. (NASDAQ: JSPR), a…
LONDON and REDWOOD CITY, Calif., May 17, 2022 (GLOBE NEWSWIRE) — Mereo BioPharma Group plc…
SOMERVILLE, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Finch Therapeutics Group, Inc. (“Finch” or “Finch…
Results from Phase 1b/2a study of efzofitimod in pulmonary sarcoidosis patients demonstrate dose-dependent improvements in…
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Entasis Therapeutics Holdings Inc. (Nasdaq: ETTX), a…
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company…
The First and Only FDA-Cleared Device Available in the United States to Provide Hemodiafiltration Therapy…
WAYNE, Pa. and ROCKVILLE, Md., May 17, 2022 (GLOBE NEWSWIRE) — Avalo Therapeutics, Inc. (Nasdaq:…
JENA, Germany, May 17, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical…
CHARLOTTESVILLE, Va., May 17, 2022 (GLOBE NEWSWIRE) — Diffusion Pharmaceuticals Inc. (NASDAQ: DFFN) (“Diffusion” or…
WARMINSTER, Pa., May 17, 2022 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS), a clinical-stage…
BOSTON, May 17, 2022 (GLOBE NEWSWIRE) — Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company…
WALTHAM, Mass., May 17, 2022 (GLOBE NEWSWIRE) — Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology…
PALO ALTO, Calif., May 17, 2022 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio”…
ANN ARBOR, Mich., May 17, 2022 (GLOBE NEWSWIRE) — Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB)…
First Quarter 2022 Revenues were $28.1 Million, Up 13% Year Over Year. Kamada Reiterates Fiscal…
Ofer Gonen, current Board member and CEO of Clal Biotechnology Industries Ltd., appointed as New…
PRESS RELEASE Emergex Vaccines Announces the Successful Coating of its Novel CD8+ T cell Adaptive…
Industry-leading software will modernize firm growth strategies and integrate conflicts data for streamlined prospecting PALO…